Prostate cancer outcomes: the three questions

Adam W Glaser; Jessica L Corner

doi:10.1016/j.eururo.2014.10.023

Prostate cancer outcomes: the three questions

Eur Urol. 2015 Mar;67(3):357-8. doi: 10.1016/j.eururo.2014.10.023. Epub 2014 Nov 10.

Authors

Adam W Glaser¹, Jessica L Corner²

Affiliations

¹ Leeds Teaching Hospitals NHS Trust, Leeds Institute of Cancer and Pathology, Leeds, UK. Electronic address: adam.glaser@leedsth.nhs.uk.
² Faculty of Health Sciences, Southampton University, Southampton, UK; Macmillan Cancer Support, London, UK.

PMID: 25454610
DOI: 10.1016/j.eururo.2014.10.023

Abstract

Enhanced survival and therapeutic choices for men with prostate cancer mandate the evaluation of the "quality of survival". An exciting series of local, national and international health outcome improvement initiatives offer the enticing prospect of assessing and improving this.

Publication types

Editorial

MeSH terms

Choice Behavior
Delivery of Health Care, Integrated / standards*
Humans
Male
Patient Participation
Patient Selection
Prostatic Neoplasms / diagnosis
Prostatic Neoplasms / mortality
Prostatic Neoplasms / therapy*
Quality Indicators, Health Care / standards*
Quality of Life
Treatment Outcome